|

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

RECRUITINGSponsored by Brigham and Women's Hospital
Actively Recruiting
SponsorBrigham and Women's Hospital
Started2000-08
Est. completion2030-08
Eligibility
Age20 Years – 90 Years
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT01258231

Summary

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Eligibility

Age: 20 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* Undergoing heart surgery
* Willing to provide consent

Exclusion Criteria:

* Enrolled in a concurrent drug or device trial that precludes concurrent enrollment

Conditions6

Atrial FibrillationGenetic Predisposition to DiseaseHeart DiseaseHeart FailureHeart; Dysfunction Postoperative, Cardiac SurgeryMyocardial Infarction

Locations3 sites

Massachusetts

1 site
Brigham and Women's Hospital
Boston, Massachusetts, 02115

Texas

2 sites
UT Southwestern Medical Center
Dallas, Texas, 75390-9068
Amanda A Fox, MD214-648-8018amanda.fox@utsouthwestern.edu
Department Texas Heart Institute at St. Luke's Episcopal Hospital
Houston, Texas, 77225

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.